Robert R. Conley, M.D. | Psychiatrist.com

Original Research

Pharmacogenomic Associations With Weight Gain in Olanzapine Treatment of Patients Without Schizophrenia

August 15, 2012

John P. Houston, Jared Kohler, Jeffrey R. Bishop, et al

Original Research

Analysis of Gene Variants Previously Associated With Iloperidone Response in Patients With Schizophrenia Who Are Treated With Risperidone

July 12, 2011

Bonnie A. Fijal, Virginia L. Stauffer, Bruce J. Kinon, et al

Original Research

Cardiovascular Disease Mortality in Patients With Chronic Schizophrenia Treated With Clozapine: A Retrospective Cohort Study

January 12, 2010

Deanna L. Kelly, Robert P. McMahon, Fang Liu, et al

Letter to the Editor

Overestimating the Prevalence of Subtherapeutic Dosing of Atypical Antipsychotics

August 15, 2009

Michael D. Stensland, Haya Ascher-Svanum, Anthony H. Lawson, et al

Original Research

A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia

April 7, 2009

Deanna L. Kelly, Robert W. Buchanan, Douglas L. Boggs, et al

Original Research

The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2006 Update

November 15, 2007

Troy A. Moore, Robert W. Buchanan, Peter F. Buckley, et al

Original Research

Clozapine Utilization and Outcomes by Race in a Public Mental Health System: 1994-2000

September 15, 2006

Deanna L. Kelly, Lisa B. Dixon, Julie A. Kreyenbuhl, et al

Original Research

Prevalence of Bone Mineral Density Loss in Korean Patients With Schizophrenia: A Cross-Sectional Study

September 15, 2006

Do-Un Jung, Robert R. Conley, Deanna L. Kelly, et al

Original Research

Thyroid Function in Treatment-Resistant Schizophrenia Patients Treated With Quetiapine, Risperidone, or Fluphenazine

January 15, 2005

Deanna L. Kelly, Robert R. Conley

Original Research

The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2003 Update

April 1, 2004

Alexander L. Miller, Catherine S. Hall, Robert W. Buchanan, et al

Academic Highlights

Guidelines for the Use of Long-Acting Injectable Atypical Antipsychotics.

January 1, 2004

John M. Kane, Robert R. Conley, Samuel J. Keith, et al

Letter to the Editor

Six-Month Review of Weight and Metabolic Parameters in Patients Receiving Clozapine, Risperidone, Olanzapine, or Quetiapine

September 1, 2003

Deanna L. Kelly, Julie Kreyenbuhl, Raymond C. Love, et al

1 2 »